Concepedia

Gregg F. Keaney

GF

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2004

Affiliations

Eisai (United States)(Current)

Yale University

Memorial Sloan Kettering Cancer Center

Moffitt Cancer Center

Gregg F. Keaney is an author at Eisai (United States) specializing in molecular oncology, alternative splicing, and oncology.

Publications per year

2004–2018

6

Publications

6

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

Michael Seiler, Akihide Yoshimi, Rachel Darman et al. · Nature Medicine · 2018 · 510 citations · Full text

, , +15

Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point

Rachel Darman, Michael Seiler, Anant A. Agrawal et al. · Cell Reports · 2015 · 463 citations · Full text

, , +14

Total Synthesis of (±)-Kalihinol C

Ryan D. White, Gregg F. Keaney, Corin D. Slown et al. · Organic Letters · 2004 · 55 citations

, , +13

Rhodium perfluorobutyramide (Rh2(pfm)4): a synthetically useful catalyst for olefin aziridinations

Gregg F. Keaney, John L. Wood · Tetrahedron Letters · 2005 · 49 citations

, , +12

H3B-8800, an Orally Bioavailable Modulator of the SF3b Complex, Shows Efficacy in Spliceosome-Mutant Myeloid Malignancies

Silvia Buonamici, Akihide Yoshimi, Michael W. Thomas et al. · Blood · 2016 · 33 citations

, , +9

1–5 of 6